The Question
Enterprise AI security is challenging for every organization. For organizations in regulated industries — healthcare, financial services, insurance, pharmaceuticals — it is compounded by a layer of sector-specific requirements that most AI security vendors have not designed for.
HIPAA was not written with LLMs in mind. SOX was not written with AI agents in mind. The EU AI Act was written with AI in mind but applies different obligations to different sectors. The intersection of AI security and regulatory compliance in these industries creates a set of requirements that are more specific, more consequential, and harder to satisfy than the baseline enterprise AI security posture.
The OWASP LLM02: Sensitive Information Disclosure is the most directly relevant risk class for regulated industries — because the "sensitive information" in question includes PHI, PII, financial records, and clinical data that carry specific regulatory obligations far beyond the general enterprise data protection standard.
Why This Matters Now
In 2024, a major U.S. health system deployed an AI-powered clinical documentation assistant to reduce physician administrative burden. Within three months, a security researcher demonstrated that the system's LLM could be induced through indirect prompt injection to surface clinical notes from patients whose records had been retrieved as context — patients whose data the querying clinician had no authorization to access.
The health system had completed a HIPAA Business Associate Agreement with the AI vendor. The BAA covered data handling in the conventional sense — storage, transmission, access controls on the infrastructure layer. It did not address the semantic access control problem: the LLM's ability to surface protected health information from its retrieval context in response to adversarially crafted queries.
This is the compliance gap that regulated industry CISOs are navigating in 2026. The existing regulatory frameworks provide real obligations and meaningful penalties. They were not designed for the threat classes that AI systems introduce, and compliance with those frameworks does not guarantee protection against those threats.
What the CURVE™ Data Shows
The 2026 Stackcurve AI Security CURVE™ Report notes that regulated industry buyers face a more complex vendor evaluation than general enterprise buyers. The relevant capabilities span the AI Governance & Compliance category — for regulatory framework alignment and audit documentation — and the AI Application Security and Data Privacy & Protection categories — for the technical controls that satisfy the compliance requirements.
Vendors with specific regulated-industry positioning include Credo AI and ValidMind for governance and compliance documentation, Knostic and BigID for sensitive data handling in AI contexts, and the broader data privacy vendor landscape for PHI and PII protection in AI training and inference pipelines.
The full vendor landscape is in the 2026 AI Security CURVE™ Report — free to download.
What the CURVE™ research found: the regulated industry buyers furthest ahead are treating AI security compliance as an extension of their existing regulatory compliance program — using the same governance structures, the same audit processes, and the same risk management frameworks they apply to other high-risk technology systems — rather than treating it as a separate AI security initiative.
The Gap Most Buyers Miss
Healthcare: HIPAA's semantic access control gap
HIPAA's minimum necessary standard requires that access to protected health information be limited to what is necessary for the authorized purpose. In traditional systems, this is enforced through role-based access controls and audit logs — a clinician with authorization to view Patient A's records cannot access Patient B's records.
In a RAG-based clinical AI system, this control breaks down. The AI's retrieval layer may retrieve context from multiple patients' records to generate a response. If that context is surfaced in the output — through an indirect injection attack, through a poorly bounded context window, or through a prompt that elicits more context than intended — HIPAA's minimum necessary standard has been violated, even though no human user deliberately accessed the unauthorized records.
The control gap: traditional HIPAA access controls operate at the data storage and transmission layer. They have no mechanism to enforce minimum-necessary constraints on what an LLM surfaces from retrieved context. Addressing this requires AI-specific access controls at the inference layer — a capability that most HIPAA compliance frameworks have not yet formalized.
Financial Services: Model risk and audit trail requirements
U.S. financial services regulators — OCC, Federal Reserve, FDIC — have published model risk management guidance (SR 11-7) that requires validation, documentation, and ongoing monitoring of models used in material business decisions. AI systems used for credit decisions, fraud detection, trading, or customer communications are subject to these requirements.
The challenge in 2026: SR 11-7 was written for statistical models with defined inputs and explainable outputs. LLMs do not have defined inputs in the traditional sense — their behavior is influenced by the full context window, retrieved documents, and system prompt instructions. Their outputs are not explainable in the way a logistic regression is explainable. Regulators are beginning to apply SR 11-7 to AI systems and finding that the standard validation and documentation requirements do not translate cleanly.
EU AI Act: High-risk AI system obligations
The EU AI Act creates specific obligations for AI systems classified as high-risk — including AI used in critical infrastructure, employment decisions, access to essential services, law enforcement, and medical devices. High-risk AI systems require conformity assessments, technical documentation, human oversight mechanisms, accuracy and robustness testing, and cybersecurity measures.
For regulated industry organizations operating in the EU, or serving EU customers, the AI Act's high-risk classification framework is the most comprehensive and most consequential AI-specific regulatory framework currently in force. The cybersecurity requirements are directly applicable to the AI security controls in this series.
Questions Your Buying Team Should Be Asking
1. For healthcare: How does your AI system enforce minimum-necessary access at the inference layer? Ask AI vendors specifically how their system prevents PHI from one patient's records from surfacing in a response generated for a query about a different patient. This is not a standard BAA question — it requires a technical answer about retrieval boundaries and output filtering at the LLM layer.
2. For financial services: How does your AI system satisfy SR 11-7 model documentation requirements? Ask for the model card or technical documentation that describes the model's inputs, outputs, known limitations, validation methodology, and ongoing monitoring approach. If the vendor cannot produce documentation that satisfies your model risk management requirements, the procurement represents a regulatory risk.
3. For EU AI Act: Have you classified your AI systems under the Act's risk tiers? The high-risk classification is not self-evident — it requires a systematic assessment of each AI system against the Act's criteria. This assessment should be completed by legal counsel with EU AI Act expertise. Do not assume that an AI system is not high-risk without completing the assessment.
4. What does your Business Associate Agreement or Data Processing Agreement actually cover for AI? Traditional BAAs and DPAs were not drafted with LLM-specific risks in mind. Review your existing agreements with AI vendors specifically for coverage of prompt injection vulnerabilities, semantic data access controls, and output monitoring. The gaps in those agreements are your uninsured exposure.
5. How are your AI security incidents documented for regulatory examination? Regulators examining AI incidents will ask for audit trails, incident logs, and response documentation. Ensure your AI security monitoring produces audit-ready documentation — not just security telemetry — before you need to present it to an examiner.
The Stackcurve Take
Regulated industries face AI security requirements that are both more specific and more consequential than the general enterprise standard. The penalties for HIPAA violations, the regulatory exposure from SR 11-7 non-compliance, and the EU AI Act's conformity requirements create a compliance driver for AI security investment that does not depend on probabilistic risk estimates — it depends on what regulators will require.
The framing that resonates with regulated-industry boards is straightforward: your existing regulatory compliance program creates obligations that extend to your AI deployments. Those obligations are not met by your current controls. Closing the gap is not optional; it is a regulatory requirement on a defined timeline.
The practical path is to extend your existing compliance program to AI rather than building a parallel AI compliance infrastructure. Use the same governance structures, the same risk management frameworks, and the same audit processes you already operate — and add the AI-specific controls that those frameworks now require but did not originally contemplate.
The 2026 Stackcurve AI Security CURVE™ Report covers the AI Governance & Compliance and Data Privacy & Protection vendor landscape most relevant to regulated industry buyers. Download it free →
Stackcurve Advisory Briefs are independent research. No vendor pays for placement, tier assignment, or editorial influence. The CURVE™ methodology is disclosed in full at stackcurve.net/research/methodology.